Submission Deadline
20 Jun 2024 (Vol 47 , Iss 06 )

Upcoming Publication
31 May 2024 (Vol 47 , Iss 05 )


Teikyo Medical Journal

Journal ID : TMJ-19-05-2022-11290
Total View : 453

Title : Metastatic Cancer patients during COVID-19 pandemic: A longitudinal study of current evidence

Abstract :

Metastatic cancer regardless its primary origin is one of the most common facet difficulties in treatment of cancers Nevertheless, patients with metastatic cancer commonly receive chemotherapy which may compromise their immune system, during the ongoing global pandemic of coronavirus disease 2019 (COVID-19), the benefit of treating patients with metastatic cancer must be weighed against the COVID-19 infection risks to patients. To date, the clinical characteristics of COVID-19-infected metastatic cancer patients remain largely unknown. The purpose of this manuscript data aims to address the status of the COVID-19 in patients with metastaticcancer and suggests an optimal approach to patients with metastatic cancer.

Full article

Journal Visit

Top Visit

Medium Visit

Less Visit

Not Visit